Two Sigma Investments, LP Edesa Biotech, Inc. Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.77 - $1.16 $11,655 - $17,558	-15,137 Reduced 56.68%	11,571 $9,000
Q1 2023 May 15, 2023	BUY	$0.91 - $2.63 $24,304 - $70,242	26,708 New	26,708 $24,000
Q2 2022 Aug 15, 2022	SELL	$1.47 - $2.94 $16,325 - $32,651	-11,106 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.72 - $5.97 $4,109 - $9,020	-1,511 Reduced 11.98%	11,106 $33,000
Q4 2021 Feb 14, 2022	BUY	$5.17 - $8.65 $65,229 - $109,137	12,617 New	12,617 $71,000
Q1 2021 May 17, 2021	SELL	$4.3 - $7.48 $96,711 - $168,232	-22,491 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.25 - $8.14 $95,586 - $183,076	22,491 New	22,491 $96,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $38.2M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.